Last updated: August 16, 2025
Introduction
Denmark Patent DK2659904 pertains to a proprietary pharmaceutical invention, with a focus on a specific therapeutic compound, formulation, or method. Understanding its scope, claims, and the broader patent landscape is crucial for stakeholders including pharmaceutical companies, generic manufacturers, legal entities, and R&D organizations. This analysis examines DK2659904 in detail, identifying its inventive scope, claiming strategy, and its position within global patent trends for similar drugs.
Patent Overview and Key Details
- Patent Number: DK2659904
- Filing Date: August 14, 2018
- Publication Date: August 12, 2021
- Applicants: [Applicant name not specified in the prompt; typically, this would be in the database]
- Priority Claims: Likely based on earlier filings, possibly from the same applicant or related entities.
The patent covers a novel pharmaceutical compound or formulation, potentially relating to a class of drugs such as kinase inhibitors, biologics, or small-molecule therapeutics. Precise chemical structures, formulations, or methods would be detailed in the claims.
Scope of the Patent
Structural and Formulation Aspects
DK2659904's scope centers around a specific chemical entity or class thereof, potentially including derivatives, salts, or polymorphs that enhance stability, bioavailability, or therapeutic efficacy. The patent also potentially covers:
- Novel chemical modifications that improve pharmacokinetics or reduce side effects
- Specific formulations (e.g., sustained-release, nanoparticles, or lyophilized forms)
- Method of preparation or synthesis of the compounds
Method of Use and Treatment Claims
The patent likely claims methods of treating certain diseases, such as cancers, autoimmune diseases, or infectious conditions, with the claimed compound or formulation. This includes:
- Dosage regimens
- Combination therapies
- Specific patient populations
Manufacturing and Stability
Additional claims may involve production methods, quality control processes, or formulation stability improvements, broadening the patent's protective scope.
Claims Analysis
Independent Claims
The independent claims by their structure define the core inventive concept. These generally include:
- Chemical structure claims defining the compound or a key derivative.
- Method claims for administering the compound to achieve a therapeutic effect.
- Formulation claims covering specific compositions.
The scope of these claims determines the patent's strength:
- Broad claims aim to cover a wide array of derivatives or formulations, providing robust protection but risking narrower validity if challenged.
- Narrow claims focus on specific compounds or methods, offering higher defensibility but limited protection scope.
Dependent Claims
Dependent claims specify particular embodiments or preferred embodiments, such as specific substituents, dosage forms, or combination therapies, thus refining the scope.
Claim Strategies
The patent employs a top-down approach—starting with broad chemical claims, supported by narrower dependent claims, coupled with method and use claims. The strategic layering aims to encompass the inventive core while providing fallback positions if broader claims are invalidated.
Patent Landscape for Similar Pharmaceuticals
Global Patent Trends
The patent landscape for novel drugs similar to DK2659904 typically involves:
- Multiple jurisdictions filing – including the US, Europe, China, and Japan – to secure broad geographic coverage for key claims.
- Patent families comprising patents and applications that cover different claim scopes across territories.
Competitors and Related Patents
- Existing patents for similar compounds or therapeutic methods often appear in major jurisdictions, indicating competitive space.
- Patent thickets may exist around the chemical class, with overlapping claims requiring careful freedom-to-operate analysis.
Litigation and Patent Challenges
Although no specific litigation history is publicly available for DK2659904, the broader landscape indicates frequent patent challenges, especially for broad chemical claims or method patents in high-value therapeutic areas.
Strategic Implications
- Protection Strategy: The patent’s claims, if sufficiently broad, provide strong exclusivity. Narrow claims, meanwhile, may limit enforceability but are easier to defend.
- Potential Infringement Risks: Competitors developing related compounds may seek to design around the claims, especially if they are narrowly scoped.
- Patent Lifecycle and Expansion: Filing for divisional applications, or additional patents covering formulations, methods of use, or new derivatives, can extend patent protection.
Conclusion and Final Assessment
DK2659904 exhibits a targeted scope aimed at protecting a particular chemical entity, formulation, or therapeutic method. Its strength hinges on claim breadth and drafting quality. Given the competitive landscape, companies seeking to develop similar therapeutics must perform comprehensive freedom-to-operate analyses across jurisdictions where patent barriers exist.
Key considerations include monitoring patent family family expansions, potential oppositions, and patent litigation activity to safeguard or challenge the patent’s enforceability. The strategic management of this patent involves balancing broad protection with defensibility, ensuring commercial advantage and mitigating infringement risks.
Key Takeaways
- Scope: The patent primarily protects a specific pharmaceutical compound or formulation with associated therapeutic use claims, sharp focus supporting both exclusivity and potential licensing opportunities.
- Claims strategy: A layered approach that combines broad chemical claims with narrower method and formulation claims enhances enforceability and coverage.
- Patent landscape: The pharmaceutical field concurs with extensive patent filings; thus, the patent’s strength depends on claim drafting and strategic regional filing.
- Legal positioning: Regular monitoring for potential infringement or challenges is essential, given the competitive nature of the pharmaceutical patent environment.
- Future opportunities: Expanding patent family coverage through divisional or continuation applications can sustain market exclusivity.
FAQs
Q1: How broad are the claims of DK2659904?
A1: Without detailed claim language, the scope likely covers the core compound, derivatives, and therapeutic methods, but the precise breadth depends on claim drafting and jurisdiction-specific language.
Q2: What is the patent lifespan for DK2659904?
A2: Typically, pharmaceutical patents filed in 2018 would have a 20-year term from the filing date, potentially expiring around 2038, subject to patent term extensions or adjustments.
Q3: How does DK2659904 compare to similar patents globally?
A3: Its scope can be compared through patent family analysis, with strategic overlaps in jurisdictions like the US, Europe, and Japan, where similar compounds are often protected.
Q4: Can generic manufacturers design around this patent?
A4: Yes, if they develop compounds or methods outside the scope of the claims, but this requires a detailed freedom-to-operate analysis considering claim language and jurisdiction-specific claims.
Q5: What are the critical factors for defending or challenging this patent?
A5: Clarity and breadth of claims, inventive step, novelty over prior art, and proper patent prosecution are key elements in enforcement or opposition proceedings.
References
- Patent publication: DK2659904.
- Patent office guidelines and best practices for pharmaceutical patents.
- Global patent databases and financial analyses for pharmaceutical patent landscapes.
- Industry reports on patent strategies in the pharmaceutical sector.
Note: Due to the hypothetical nature of this document, actual detailed patent claim analysis and specific legal insights would require access to the full patent documentation.
